A frequently occurring mutation in the lipoprotein lipase gene (Asn291Ser) results in altered postprandial chylomicron triglyceride and retinyl palmitate response in normolipidemic carriers

Journal of Lipid Research

Volumn 37, Issue 8, 1996, Pages 1675-1684

  Pimstone, Simon N ^a   Clee, Susanne M ^a   Gagné, S Eric ^a   Miao, Li ^a   Zhang, Hanfang ^a   Stein, Evan A ^b   Hayden, Michael R ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b Med Res Laboratories International   (United States)

Author keywords

chylomicron; lipoprotein lipase; normolipidemic; oral fat load; postprandial response

Indexed keywords

APOLIPOPROTEIN C2; APOLIPOPROTEIN E; CHYLOMICRON; HIGH DENSITY LIPOPROTEIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INTERMEDIATE DENSITY LIPOPROTEIN; LIPOPROTEIN LIPASE; LOW DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; RETINOL PALMITATE; TRIACYLGLYCEROL; VERY LOW DENSITY LIPOPROTEIN; VERY LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ADULT; ARTICLE; CASE REPORT; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME DEFECT; FEMALE; GENE MUTATION; GENOTYPE; HETEROZYGOTE; HUMAN; LIPID DIET; LIPOPROTEIN BLOOD LEVEL; LIPOPROTEIN METABOLISM; MALE; POSTPRANDIAL STATE; PRIORITY JOURNAL; TRIACYLGLYCEROL BLOOD LEVEL;

ADULT; CHYLOMICRONS; COHORT STUDIES; DIETARY FATS; FEMALE; HUMANS; LIPOPROTEIN LIPASE; MALE; MIDDLE AGED; MUTATION; POSTPRANDIAL PERIOD; TRIGLYCERIDES; VITAMIN A;

EID: 0029815358     PISSN: 00222275     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. Brunzell, J. D. 1995. Familial lipoprotein lipase deficiency and other causes of the chylomicronemia syndrome. In The Metabolic Basis of Inherited Disease. 7th ed. C. R. Scriver, A. L. Beaudet, W. S. Sly and D. Valle, editors. McGraw-Hill Book Co., New York. Volume II. 1913-1932.
2. Hayden, M. R., and Y. Ma. 1990. Molecular genetics of lipoprotein lipase deficiency. Mol. Cell. Biochem. 113: 171-176.
3. Ma, Y., T. C. Ooi, M. S. Liu, H. Zhang, R. McPherson, A. L. Edwards, I. J. Forsythe, J. Frohlich, J. D. Brunzell, and M. R. Hayden. 1994. High frequency of mutations in the human lipoprotein lipase gene in pregnancy-induced chylomicronemia: possible association with apolipoprotein E2 isoform. J. Lipid Res. 35: 1066-1075.
4. Reymer, P. W. A., S. E. Gagné, B. E. Groenemeyer, H. Zhang, I. Forsythe, H. Jansen, J. C. Seidell, D. Kromhout, K. E. Lie, J. Kastelein, and M. R. Hayden. 1995. A lipoprotein lipase mutation (Asn291Ser) is associated with reduced HDL cholesterol levels in premature atherosclerosis. Nat. Genet. 10: 28-34.
5. Zhang, H., P. W. A. Reymer, M-S. Liu, I. J. Forsythe, B. E. Groenemeyer, J. Frohlich, J. D. Brunzell, J. J. P. Kastelein, M. R. Hayden, and Y. Ma. 1995. Patients with apoE3 deficiency (E2/2, E3/2, and E4/2) who manifest with hyperlipidemia have increased frequency of an Asn291Ser mutation in the human LPL gene. Arterioscler. Thromb. 15: 1695-1703.
6. Reymer, P. W. A., B. E. Groenemeyer, S. E. Gagné, L. Miao, E. E. G. Appelman, J. C. Seidell, D. Kromhout, S. M. Bijvoet, K. vd Oever, T. Bruin, M. R. Hayden, and J. J. P. Kastelein. 1995. A frequently occurring mutation in the lipoprotein lipase gene (Asn291Ser) contributes to the expression of familial combined hyperlipidemia. Hum. Mol. Genet. 4: 1543-1549.
7. Miesenböck, G., B. Hölzl, B. Foger, E. Brandstatter, B. Paulweber, F. Sandhofer, and J. R. Patsch. 1993. Heterozygous lipoprotein lipase deficiency due to a missense mutation as the cause of impaired triglyceride tolerance with multiple lipoprotein abnormalities. J. Clin. Invest. 91: 448-455.
8. Sprecher, D. L., S. L. Knauer, D. M. Black, L. A. Kaplan, A. A. Akeson, M. Dusing, D. Lattier, E. A. Stein, M. Rymaszewski, and D. A. Wiginton. 1991. Chylomicron-retinyl palmitate clearance in type I hyperlipidemic families. J. Clin. Invest. 88: 985-994.
9. Cohen, J. C., T. D. Noakes, and A. J. Spinnler Benade. 1989. Postprandial lipemia and chylomicron clearance in athletes and in sedentary men. Am. J. Clin. Nutr. 49: 443-447.
10. Lipid Research Clinics Program. 1982. Manual of Laboratory Operations: Lipid and Lipoprotein Analysis. Washington D.C., U.S. Department of Health, Education and Welfare. 1982. Publication (NIH) 75-628.
11. Myers, G. L., G. R. Cooper, C. L. Winn, and S. J. Smith. 1989. The Centers for Disease Control National Heart, Lung, and Blood Institute Lipid Standardization Program: an approach to accurate and precise lipid measurements. Clin. Lab. Med. 9: 105-135.
12. Warnick, G. R., and J. J. Albers. 1978. A comprehensive evaluation of the heparin manganese precipitation procedure for estimating high-density lipoprotein cholesterol. J. Lipid Res. 19: 65-76.
13. Smith, S. J., G. R. Cooper, L. O. Henderson, and W. H. Hannon. 1987. An international collaborative study on standardization of apolipoproteins A-I and B. Clin. Chem. 33: 2240-2251.
14. Parra, H. J., G. Mezdourh, J. M. Bard, and J. C. Fruchart. 1990. Differential electroimmunoassay of human LpA-I lipoprotein particles on ready-to-use plates. Clin. Chem. 36: 1431-1435.
15. Nilssohn-Ehle, P., and M. C. Scholtz. 1976. A stable, radioactive substrate emulsion for assay of lipoprotein lipase. J. Lipid Res. 17: 536-541.
16. Babirak, S. P., P. H. Iverius, W. Y. Fujimoto, and J. D. Brunzell. 1989. Detection and characterization of heterozygous state for lipoprotein lipase deficiency. Arteriosclerosis. 9: 326-334.
17. Technical Tips. 1989. An efficient salt-chloroform extraction of DNA from blood and tissue. Trends Genet. 5: 391.
18. Mailly, F., Y. Tugrul, P. W. A. Reymer, T. Bruin, M. Seed, B. J. Groenemeyer, A. Asplund-Carlson, D. Vallance, A. F. Winder, G. J. Miller, J. J. P. Kastelein, A. Hamsten, G. Olivecrona, S. E. Humphries, and P. J. Talmud. 1995. A common variant in the gene for lipoprotein lipase (Asp9Asn): functional implications and prevalence in normal and hyperlipidemic subjects. Arterioscler. Thromb. Vasc. Biol. 15: 468-478.
19. Mattu, R. K. E. W. A. Needham, R. Morgan, A. Rees, A. K. Hackshaw, J. Stocks, P. C. Elwood, and D. J. Galton. 1994. DNA variants at the LPL gene locus associate with angiographically defined severity of atherosclerosis and serum lipoprotein levels in a Welsh population. Arterioscler. Thromb. 14: 1090-1097.
20. Gagné, S. E., J. Genest, Jr., H. Zhang, L. A. Clarke, and M. R. Hayden. 1994. Analysis of DNA changes in the LPL gene in patients with familial combined hyperlipidemia. Arterioscler. Thromb. 14: 1250-1257.
21. Main, B. F., P. J. H. Jones, R. T. A. MacGillivray, and D. K. Banfield. 1991. Apolipoprotein E genotyping using the polymerase chain reaction and allele-specific oligonucleotide primers. J. Lipid Res. 32: 183-187.
22. Hixson, J. E., and T. E. Vernier. 1990. Restriction isotyping of human apolipoprotein E by gene amplification and cleavage with HhaI. J. Lipid Res. 31: 545-548.
23. Peltonen, P., J. Marniemi, E. Hietanen, I. Vuori, and C. Enholm. 1981. Changes in serum lipids, lipoproteins and heparin releasable lipolytic enzymes during moderate physical training in man: a longitudinal study. Metabolism. 30: 518-526.
24. Nikkilä, E. A., M-R. Taskinen, S. Rehunen, and M. Härkönen. 1978. Lipoprotein lipase activity in adipose tissue and skeletal muscle of runners: relation to serum lipoproteins. Metabolism. 27: 1661-1667.
25. Wirth, A., C. Diehm, W. Hanel, J. Welte, and I. Vogel. 1985. Training-induced changes in serum lipids, fat tolerance, and adipose tissue metabolism in patients with hypertriglyceridemia. Atherosclerosis. 54: 263-271.
26. O'Meara, N. M., G. F. Lewis, V. G. Cabana, P. H. Iverius, G. S. Getz, and K. S. Polonsky. 1992. Role of basal triglyceride and high density lipoprotein in determination of postprandial lipid and lipoprotein responses. J. Clin. Endocrinol. Metab. 75: 465-471.
27. Karpe, F., G. Steiner, T. Olivecrona, L. A. Carlson, and A. Hamsten. 1993. Metabolism of triglyceride-rich lipoproteins during alimentary lipemia. J. Clin. Invest. 9: 748-758.
28. Cohen, J. C., J. Stray-Gunderson, and S. M. Grundy. 1991. Dissociation between postprandial lipemia and high density lipoprotein cholesterol concentrations in endurance-trained men. Arterioscler. Thromb. 11: 838-843.
29. Syvänne, M., M. Rosseneu, C. Labeur, H. Hilden, and M-R. Taskinen. 1993. Enrichment with apolipoprotein E characterizes postprandial TG-rich lipoproteins in patients with non-insulin-dependent diabetes mellitus and coronary artery disease: a preliminary report. Atherosclerosis. 105: 25-34.
30. Funke, H., and G. Assmann. 1995. The lowdown on lipoprotein lipase. Nat. Genet. 10: 6-7.
31. Brown, A. J., and D. C. K. Roberts. 1991. The effect of fasting triacylglyceride concentration and apolipoprotein E polymorphism on postprandial lipemia. Arterioscler. Thromb. 11: 1737-1744.
32. Brenninkmeijer, B. J., P. M. J. Stuyt, P. N. M. Demacker, A. F. H. Stalenhoef, and A. van't Laar. 1987. Catabolism of chylomicron remnants in normolipidemic subjects in relation to the apolipoprotein E phenotype. J. Lipid Res. 28: 361-370.
33. Weintraub, M. S., S. Eisenberg, and J. L. Breslow. 1987. Dietary fat clearance in normal subjects is regulated by genetic variation in apolipoprotein E. J. Clin. Invest. 80: 1571-1577.
34. Boerwinkle, E., S. Brown, A. R. Sharret, G. Heiss, and W. Patsch. 1994. Apolipoprotein E polymorphism influences postprandial retinyl palmitate but not triglyceride concentrations. Am. J. Hum. Genet. 54: 341-360.
35. Johnson, E. J., S. D. Krasinski, and R. M. Russell. 1992. Sex differences in postabsorptive plasma vitamin A transport. Am. J. Clin. Nutr. 56: 911-916.
36. Zsigmond, E., E. Scheffler, T. M. Forte, R. Potenz, W. Wu, and L. Chan. 1994. Transgenic mice expressing human lipoprotein lipase driven by the mouse metallothionein promoter. J. Biol. Chem. 269: 18757-18766.
37. Peterson, J., B. E. Bihain, G. Bengtsson-Olivecrona, R. J. Deckelbaum, Y. A. Carpentier, and T. Olivecrona. 1990. Fatty acid control of lipoprotein lipase: a link between energy metabolism and lipid transport. Proc. Natl. Acad. Sci. USA. 87: 909-913.
38. Bijvoet, S., S. E. Gagné, S. Moorjani, C. Gagné, H. E. Henderson, J-C. Fruchart, J. Dallongeville, P. Alaupovic, M. Prins, J. J. P. Kastelein, and M. R. Hayden. 1996. Alterations in plasma lipoproteins and apolipoproteins before the age of 40 in heterozygotes for LPL deficiency. J. Lipid Res. 37: 640-650.
39. Wang, C-S., W. J. McConathy, H. U. Kloer, and P. Alaupovic. 1985. Modulation of lipoprotein lipase activity by apolipoproteins: effect of apolipoprotein C-III. J. Clin. Invest. 75: 384-390.
40. McConathy, W. J., J. C. Gesquire, H. Bass, A. Tartar, J-C. Fruchart, and C-S. Wang. 1992. Inhibition of lipoprotein lipase activity by synthetic peptides of apolipoprotein C-III. J. Lipid Res. 33: 995-1003.